アカディア・ヘルスケアに関するコメント

Substantial insider selling of Acadia Healthcare shares suggests insiders believe the shares are overpriced. Lack of insider purchases and recent selling activity raises concerns about the company's future. However, high level of insider ownership indicates management's consideration for shareholders' interests.

The upward trend in Acadia Healthcare Company's ROCE and the efficient use of capital indicate a promising future for the company. The 183% total return over the last five years suggests that investors are optimistic about the company's future performance.

Despite EPS growth outpacing share price increase, the market is more cautious towards the stock. The company's 5-year track record of 25% annual TSR is seen positively, even as share price gains slow.

Insider selling activity, lack of buying, and insider ownership at Acadia Healthcare Company must draw investor's attention. But, some warning signs about the company should not be ignored.